Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30

$1.56+0.07 (+4.70%)

Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –

Purple Biotech ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Purple Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?